Placeholder

Global Candesartan Cilexetil (CAS 145040-37-5) Market Outlook 2016-2021

Published by: | Published Date: August, 2016 | Number of pages: 91

$2,800$5,600

Clear

Part 1. Scope of Report
1.1 Methodology
1.2 Geographic Scope
1.3 Years Considered

Part 2. Introduction
2.1 Definition
2.2 Current Scenario
2.2 Future Scenario

Part.3 Value Chain Analysis
3.1 Upstream
3.2 Downstream

Part 4. Manufacture
4.1 Manufacturing Process
4.2 Issues and Trends
4.3 Manufacturing Costs

Part 5. Worldwide Key Vendors
5.1 Company A
5.1.1 Business Overview
5.1.2 Products Offered
5.1.3 Business Performance
5.2 Company B
5.3 Company C
5.4 Company D
5.5 Company E
5.6 Company F
5.7 Company G
5.8 Company H
5.9 Company I
5.10 Company J

Part 6. Market Overview
6.1 Global Production Volume 2011-2016
6.2 Production Volume by Region 2011-2016
6.2.1 North America
6.2.2 EMEA
6.2.3 Asia-Pacific
6.2.4 ROW
6.3 Global Production Value 2011-2016
6.4 Production Value by Region
6.4.1 North America
6.4.2 EMEA
6.4.3 Asia-Pacific
6.4.4 ROW

Part 7. Consumption Pattern
7.1 Regional Consumption
7.1.1 North America
7.1.2 EMEA
7.1.3 Asia-Pacific
7.1.4 ROW
7.2 Global Consumption by Application

Part 8. Market Forecast
8.1 Market Size by Volume
8.1.1 North America
8.1.2 EMEA
8.1.3 Asia-Pacific
8.1.4 ROW
8.2 Market Size by Value
8.2.1 North America
8.2.2 EMEA
8.2.3 Asia-Pacific
8.2.4 ROW
8.3 Regional Consumption Forecast
8.3.1 North America
8.3.2 EMEA
8.3.3 Asia-Pacific
8.3.4 ROW
8.4 Consumption Forecast by Application

Part 9. Market Dynamics
9.1 Market Drivers
9.2 Market Constraints
9.3 Market Strategies

Part 10 Key Events
10.1 Mergers & Acquisitions
10.2 New Product Launches
10.3 Expansions
10.4 Other Developments
Takeda Pharmaceutical (Japan), Taj Pharmaceuticals (India),Lupin (India), Zhejiang Tianyu (China), Zhuhai Rundu (China), TIPR Pharmaceutical (China), Weihai Disu (China), Zhejiang Huahai (China), Jiangxi Synergy (China)

Figure Global Candesartan Cilexetil (CAS 145040-37-5) Production Volume (Unit) 2011-2016
Figure Global Candesartan Cilexetil (CAS 145040-37-5) Production Value (M USD) 2011-2016
Figure Top 10 Candesartan Cilexetil (CAS 145040-37-5) Vendors Production Volume Share 2015
Figure Top 10 Candesartan Cilexetil (CAS 145040-37-5) Vendors Production Value Share 2015
Figure Regional Candesartan Cilexetil (CAS 145040-37-5) Production (Unit) 2015
Figure Regional Candesartan Cilexetil (CAS 145040-37-5) Production Value (M USD) 2015
Table Raw Material Materials Suppliers
Figure Global Candesartan Cilexetil (CAS 145040-37-5) Consumption Pattern 2015
Figure Manufacturing Cost Structure
Figure Company A Candesartan Cilexetil (CAS 145040-37-5) Products
Table Company A Financial Performance 2011-2016
Figure Company A Market Share 2011-2016
Figure Company B Candesartan Cilexetil (CAS 145040-37-5) Products
Table Company B Financial Performance 2011-2016
Figure Company B Market Share 2011-2016
Figure Company C Candesartan Cilexetil (CAS 145040-37-5) Products
Table Company C Financial Performance 2011-2016
Figure Company C Market Share 2011-2016
Figure Company D Candesartan Cilexetil (CAS 145040-37-5) Products
Table Company D Financial Performance 2011-2016
Figure Company D Market Share 2011-2016
Figure Company E Candesartan Cilexetil (CAS 145040-37-5) Products
Table Company E Financial Performance 2011-2016
Figure Company E Market Share 2011-2016
Figure Company F Candesartan Cilexetil (CAS 145040-37-5) Products
Table Company F Financial Performance 2011-2016
Figure Company F Market Share 2011-2016
Figure Company G Candesartan Cilexetil (CAS 145040-37-5) Products
Table Company G Financial Performance 2011-2016
Figure Company G Market Share 2011-2016
Figure Company H Candesartan Cilexetil (CAS 145040-37-5) Products
Table Company H Financial Performance 2011-2016
Figure Company H Market Share 2011-2016
Figure Company I Candesartan Cilexetil (CAS 145040-37-5) Products
Table Company I Financial Performance 2011-2016
Figure Company I Market Share 2011-2016
Figure Company J Candesartan Cilexetil (CAS 145040-37-5) Products
Table Company J Financial Performance 2011-2016
Figure Company J Market Share 2011-2016
Table Global Key Candesartan Cilexetil (CAS 145040-37-5) Vendors Production (Unit) 2011-2016
Table Global Key Candesartan Cilexetil (CAS 145040-37-5) Vendors Production Share 2011-2016
Figure Global Candesartan Cilexetil (CAS 145040-37-5) Capacity & Production (Unit), Capacity Utilization 2011-2016
Figure Global Top 10 Candesartan Cilexetil (CAS 145040-37-5) Vendors Production (Unit) 2011-2016
Table Global Top 10 Candesartan Cilexetil (CAS 145040-37-5) Vendors Production (Unit) 2011
Table Global Top 10 Candesartan Cilexetil (CAS 145040-37-5) Vendors Production (Unit) 2012
Table Global Top 10 Candesartan Cilexetil (CAS 145040-37-5) Vendors Production (Unit) 2013
Table Global Top 10 Candesartan Cilexetil (CAS 145040-37-5) Vendors Production (Unit) 2014
Table Global Top 10 Candesartan Cilexetil (CAS 145040-37-5) Vendors Production (Unit) 2015
Table Global Top 10 Candesartan Cilexetil (CAS 145040-37-5) Vendors Production (Unit) 2016
Figure Candesartan Cilexetil (CAS 145040-37-5) Production Volume (Unit) 2011-2016
Table Global Production Volume (Unit) 2011-2016
Table Global Production Volume Share 2011-2016
Figure North America Candesartan Cilexetil (CAS 145040-37-5) Capacity & Production (Unit)
Figure North America Production Share Trend
Figure EMEA Candesartan Cilexetil (CAS 145040-37-5) Capacity & Production (Unit)
Figure EMEA Production Share Trend
Figure Asia-Pacific Candesartan Cilexetil (CAS 145040-37-5) Capacity & Production (Unit)
Figure Asia-Pacific Production Share Trend
Figure ROW Candesartan Cilexetil (CAS 145040-37-5) Capacity & Production (Unit)
Figure ROW Production Share Trend Change
Figure Global Candesartan Cilexetil (CAS 145040-37-5) Production Value (M USD), Growth Rate
Table Global Key Candesartan Cilexetil (CAS 145040-37-5) Vendors Production Value (M USD) 2011-2016
Table Global Key Candesartan Cilexetil (CAS 145040-37-5) Vendors Production Value Share 2011-2016
Figure Global Top 10 Candesartan Cilexetil (CAS 145040-37-5) Vendors Production Value (M USD) 2011-2016
Table Global Top 10 Candesartan Cilexetil (CAS 145040-37-5) Vendors Production Value (M USD) 2011
Table Global Top 10 Candesartan Cilexetil (CAS 145040-37-5) Vendors Production Value (M USD) 2012
Table Global Top 10 Candesartan Cilexetil (CAS 145040-37-5) Vendors Production Value (M USD) 2013
Table Global Top 10 Candesartan Cilexetil (CAS 145040-37-5) Vendors Production Value (M USD) 2014
Table Global Top 10 Candesartan Cilexetil (CAS 145040-37-5) Vendors Production Value (M USD) 2015
Table Global Top 10 Candesartan Cilexetil (CAS 145040-37-5) Vendors Production Value (M USD) 2016
Figure Candesartan Cilexetil (CAS 145040-37-5) Prices (USD/Ton) 2016
Figure Candesartan Cilexetil (CAS 145040-37-5) Gross Margin 2016
Figure Candesartan Cilexetil (CAS 145040-37-5) Production Value (M USD) By Region 2011-2016
Table Global Candesartan Cilexetil (CAS 145040-37-5) Production Value (M USD) 2011-2016
Table Global Candesartan Cilexetil (CAS 145040-37-5) Production Value Share 2011-2016
Figure North America Production Value (M USD), Growth Rate
Figure North America Candesartan Cilexetil (CAS 145040-37-5) Production Value Share Trend
Figure EMEA Production Value (M USD), Growth Rate
Figure EMEA Candesartan Cilexetil (CAS 145040-37-5) Production Value Share Trend
Figure Asia-Pacific Production Value (M USD), Growth Rate
Figure Asia-Pacific Candesartan Cilexetil (CAS 145040-37-5) Production Value Share Trend
Figure ROW Production Value (M USD), Growth Rate
Figure ROW Candesartan Cilexetil (CAS 145040-37-5) Production Value Share Trend
Figure Global Candesartan Cilexetil (CAS 145040-37-5) Consumption Volume (Unit) 2015
Table Regional Candesartan Cilexetil (CAS 145040-37-5) Consumption Volume (Unit) 2011-2016
Table Regional Candesartan Cilexetil (CAS 145040-37-5) Consumption Volume Share 2011-2016
Figure Candesartan Cilexetil (CAS 145040-37-5) Consumption in North America 2011-2016
Figure Candesartan Cilexetil (CAS 145040-37-5) Consumption in EMEA 2011-2016
Figure Candesartan Cilexetil (CAS 145040-37-5) Consumption in Asia-Pacific 2011-2016
Figure Candesartan Cilexetil (CAS 145040-37-5) Consumption in ROW 2011-2016
Figure Global Candesartan Cilexetil (CAS 145040-37-5) Consumption Volume (Unit) 2016
Table Global Candesartan Cilexetil (CAS 145040-37-5) Consumption Volume (Unit) 2011-2016
Table Global Candesartan Cilexetil (CAS 145040-37-5) Consumption Volume Share 2011-2016
Figure Global Candesartan Cilexetil (CAS 145040-37-5) Production (Unit) Forecast 2016-2021
Table Global Candesartan Cilexetil (CAS 145040-37-5) Production (Unit) 2016-2021
Table Global Candesartan Cilexetil (CAS 145040-37-5) Production Share 2016-2021
Figure North Candesartan Cilexetil (CAS 145040-37-5) Production (Unit) Forecast 2016-2021
Figure EMEA Candesartan Cilexetil (CAS 145040-37-5) Production (Unit) Forecast 2016-2021
Figure Asia-Pacific Candesartan Cilexetil (CAS 145040-37-5) Production (Unit) Forecast 2016-2021
Figure ROW Candesartan Cilexetil (CAS 145040-37-5) Production (Unit) Forecast 2016-2021
Figure Global Candesartan Cilexetil (CAS 145040-37-5) Revenue (M USD) Forecast 2016-2021
Table Global Candesartan Cilexetil (CAS 145040-37-5) Revenue (M USD) 2016-2021
Table Global Candesartan Cilexetil (CAS 145040-37-5) Revenue Share 2016-2021
Figure North America Candesartan Cilexetil (CAS 145040-37-5) Revenue (M USD) Forecast 2016-2021
Figure EMEA Candesartan Cilexetil (CAS 145040-37-5) Revenue (M USD) Forecast 2016-2021
Figure Asia-Pacific Candesartan Cilexetil (CAS 145040-37-5) Revenue (M USD) Forecast 2016-2021
Figure ROW Candesartan Cilexetil (CAS 145040-37-5) Revenue (M USD) Forecast 2016-2021
Figure Global Candesartan Cilexetil (CAS 145040-37-5) Consumption Volume (Unit) 2016-2021
Table Global Candesartan Cilexetil (CAS 145040-37-5) Consumption Volume (Unit) 2016-2021
Table Global Candesartan Cilexetil (CAS 145040-37-5) Consumption Volume Share 2016-2021
Figure North America Candesartan Cilexetil (CAS 145040-37-5) Consumption (Unit) Forecast
Figure EMEA Candesartan Cilexetil (CAS 145040-37-5) Consumption (Unit) Forecast
Figure Asia-Pacific Candesartan Cilexetil (CAS 145040-37-5) Consumption (Unit) Forecast
Figure ROW Candesartan Cilexetil (CAS 145040-37-5) Consumption (Unit) Forecast
Figure Global Candesartan Cilexetil (CAS 145040-37-5) Consumption Volume (Unit) 2021
Table Global Candesartan Cilexetil (CAS 145040-37-5) Consumption Volume (Unit) 2016-2021
Table Global Candesartan Cilexetil (CAS 145040-37-5) Consumption Volume Share 2016-2021
Table Key Strategies for Candesartan Cilexetil (CAS 145040-37-5) Multinational Corporations
Table Key Strategies for Candesartan Cilexetil (CAS 145040-37-5) Emerging-Market Players
Refer Data Tables Tab
Candesartan (rINN) is an angiotensin II receptor antagonist used mainly for the treatment of hypertension. The prodrug candesartan cilexetil is marketed by AstraZeneca and Takeda Pharmaceuticals, commonly under the trade names Blopress, Atacand, Amias, and Ratacand. It is available in generic form. Candesartan is marketed as the cyclohexyl 1-hydroxyethyl carbonate (cilexetil) ester, known as candesartan cilexetil. Candesartan cilexetil is metabolised completely by esterases in the intestinal wall during absorption to the active candesartan moieity.

This report provides detailed analysis of worldwide markets for Candesartan Cilexetil (CAS 145040-37-5) from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Candesartan Cilexetil (CAS 145040-37-5) market and further lays out an analysis of the factors influencing the supply/demand for Candesartan Cilexetil (CAS 145040-37-5), and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.

GCC's report, Global Candesartan Cilexetil (CAS 145040-37-5) Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Candesartan Cilexetil (CAS 145040-37-5) market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Candesartan Cilexetil (CAS 145040-37-5) market are Takeda Pharmaceutical (Japan), Taj Pharmaceuticals (India),Lupin (India), Zhejiang Tianyu (China), Zhuhai Rundu (China), TIPR Pharmaceutical (China), Weihai Disu (China), Zhejiang Huahai (China), Jiangxi Synergy (China), among others.

The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Candesartan Cilexetil (CAS 145040-37-5) industry has been provided.